The Italian outfit has had an uncompetitive pace throughout the season so far and is far off from their rivals. The Sprint qualifying session at Miami came to an end as F1 makes its first trip to ...

3Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama. 7O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama. Search for ...

Mr Downer told Sky News host Chris Kenny that the Coalition must focus on Labor’s renewable policy, which has been “driving up” electricity prices. “And making our country uncompetitive.” ...

Diseases that involve pathological hyperactivity of NMDARs can be treated clinically through inhibition by channel blocking drugs. NMDAR channel block can occur via two known mechanisms. First, in ...

Google is fighting three separate antitrust lawsuits for uncompetitive pricing/advertising practices. They are supposedly harming consumers. Really? The consumer surplus provided by Google is ...

In it, plaintiffs alleged that the system had used its power in an uncompetitive healthcare market to force health plans into contracts that only included inpatient services at Sutter-affiliated ...

Interest in developing selective inhibitors has produced tool compounds for the inactivation or degradation of AKR1C3 with varying degrees of selectivity among the 14 known AKR proteins. Selectivity ...

Crossing TRGL mice with a model of a neurodegenerative disease, the Q175 mouse model of HD, has enabled us to assess disease-related autophagy alterations in the Q175 and TRGL/Q175 models and their ...

Led by AbbVie’s Humira, biologic TNF inhibitors transformed the treatment of autoimmune diseases over the past 20 years. However, the biologic modality can cause adverse effects and loss of ...

The FDA approved the PD-1 inhibitor penpulimab, with two indications, for treating non-keratinizing nasopharyngeal carcinoma (NPC) in adults. No trade name was indicated for the drug. The first ...

Image credit: Shutterstock / LCV Sanofi will halt the development of its oral tumour necrosis factor (TNF) inhibitor balinatunfib as a monotherapy after it failed to reach the primary endpoint in a ...